Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1145

1.

Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: Post-hoc analysis of an all-case post-marketing surveillance study of iguratimod.

Ishiguro N, Shibata K, Yoshimura A, Ikeuchi S, Ishii M.

Mod Rheumatol. 2019 Aug 12:1-7. doi: 10.1080/14397595.2019.1649229. [Epub ahead of print]

PMID:
31403345
2.

In Vitro Conversion of Activated T Cells into Stem Cell Memory-Like T Cells.

Kondo T, Imura Y, Ando M, Chikuma S, Yoshimura A.

Methods Mol Biol. 2019;2048:41-51. doi: 10.1007/978-1-4939-9728-2_4.

PMID:
31396927
3.

Investigation of the predictors of the response to Iguratimod therapy: A post-hoc analysis of post-marketing surveillance study.

Ishiguro N, Shibata K, Yoshimura A, Ikeuchi S, Ishii M.

Mod Rheumatol. 2019 Aug 8:1-7. doi: 10.1080/14397595.2019.1649110. [Epub ahead of print]

PMID:
31393189
4.

Periodontal Disease in Patients Receiving Dialysis.

Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H.

Int J Mol Sci. 2019 Aug 3;20(15). pii: E3805. doi: 10.3390/ijms20153805. Review.

5.

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer.

Yoshimura A, Uchino J, Hasegawa K, Tsuji T, Shiotsu S, Yuba T, Takumi C, Yamada T, Takayama K, Hiraoka N.

Transl Lung Cancer Res. 2019 Jun;8(3):227-234. doi: 10.21037/tlcr.2019.06.08.

6.

Regulatory T Cells: Pathophysiological Roles and Clinical Applications.

Sakai R, Komai K, Iizuka-Koga M, Yoshimura A, Ito M.

Keio J Med. 2019 Jul 26. doi: 10.2302/kjm.2019-0003-OA. [Epub ahead of print]

7.

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.

Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H.

Int J Mol Sci. 2019 Jul 11;20(14). pii: E3413. doi: 10.3390/ijms20143413. Review.

8.

Presence of small residual malignant lesions in pathologic complete response after neo-adjuvant chemotherapy in patients with breast cancer.

Iwase M, Hattori M, Sawaki M, Yoshimura A, Kotani H, Gondo N, Adachi Y, Kataoka A, Onishi S, Sugino K, Horisawa N, Mori M, Terada M, Iwata H.

Breast J. 2019 Jul 18. doi: 10.1111/tbj.13473. [Epub ahead of print] No abstract available.

PMID:
31318111
9.

Background Music Dependent Reduction of Aversive Perception and Its Relation to P3 Amplitude Reduction and Increased Heart Rate.

Matsuo M, Masuda F, Sumi Y, Takahashi M, Yoshimura A, Yamada N, Kadotani H.

Front Hum Neurosci. 2019 Jun 27;13:184. doi: 10.3389/fnhum.2019.00184. eCollection 2019.

10.

2-Iodoxybenzoic acid ditriflate: the most powerful hypervalent iodine(v) oxidant.

Yusubov MS, Soldatova NS, Postnikov PS, Valiev RR, Yoshimura A, Wirth T, Nemykin VN, Zhdankin VV.

Chem Commun (Camb). 2019 Jul 11;55(54):7760-7763. doi: 10.1039/c9cc04203b. Epub 2019 Jun 18.

PMID:
31209449
11.

Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.

Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2018-214885. doi: 10.1136/annrheumdis-2018-214885. [Epub ahead of print]

12.

A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types.

Hattori M, Hagiwara S, Kotani H, Tatematsu M, Tachi M, Hijioka S, Shimizu J, Andoh M, Mizuno Y, Sawaki M, Yoshimura A, Gondo N, Adachi Y, Yoshimura K, Iwata H.

Int J Clin Oncol. 2019 Jun 1. doi: 10.1007/s10147-019-01476-0. [Epub ahead of print]

PMID:
31154565
13.

Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.

Sato A, Takagi K, Miki Y, Yoshimura A, Hara M, Ishida T, Sasano H, Suzuki T.

Histol Histopathol. 2019 May 31:18130. doi: 10.14670/HH-18-130. [Epub ahead of print]

PMID:
31149728
14.

Laparoscopic Percutaneous Endoscopic Gastrostomy Is Useful for Elderly.

Tanaka T, Ueda T, Yokoyama T, Sadamitsu T, Yoshimura A, Horiuchi H, Sawai M, Matsumoto M.

JSLS. 2019 Apr-Jun;23(2). pii: e2019.00011. doi: 10.4293/JSLS.2019.00011.

15.

Effects of Self-myofascial Release Using a Foam Roller on Range of Motion and Morphological Changes in Muscle: A Crossover Study.

Yoshimura A, Inami T, Schleip R, Mineta S, Shudo K, Hirose N.

J Strength Cond Res. 2019 May 24. doi: 10.1519/JSC.0000000000003196. [Epub ahead of print]

PMID:
31136541
16.

PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability.

Kawarai T, Yamazaki H, Miyamoto R, Takamatsu N, Mori A, Osaki Y, Orlacchio A, Nodera H, Hashiguchi A, Higuchi Y, Yoshimura A, Takashima H, Kaji R.

Neuromuscul Disord. 2019 Jun;29(6):422-426. doi: 10.1016/j.nmd.2019.03.010. Epub 2019 Mar 28.

PMID:
31122831
17.

A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor.

Terada M, Gondo N, Sawaki M, Hattori M, Yoshimura A, Kotani H, Adachi Y, Iwase M, Kataoka A, Sugino K, Mori M, Horisawa N, Ozaki Y, Iwata H.

Surg Case Rep. 2019 May 10;5(1):77. doi: 10.1186/s40792-019-0635-4.

18.

WRNIP1 Controls the Amount of PrimPol.

Yoshimura A, Oikawa M, Jinbo H, Hasegawa Y, Enomoto T, Seki M.

Biol Pharm Bull. 2019;42(5):764-769. doi: 10.1248/bpb.b18-00955.

19.

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer.

Chihara Y, Yoshimura A, Date K, Takemura Y, Tamiya N, Kohno Y, Imabayashi T, Takeuchi M, Kaneko Y, Yamada T, Ueda M, Arimoto T, Uchino J, Iwasaki Y, Takayama K.

Oncologist. 2019 Aug;24(8):1033-e617. doi: 10.1634/theoncologist.2019-0290. Epub 2019 Apr 30.

20.

Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.

Ueno N, Banno S, Endo Y, Tamura M, Sugaya K, Hashigaki S, Ohki E, Yoshimura A, Gemma A.

Jpn J Clin Oncol. 2019 Apr 22. pii: hyz049. doi: 10.1093/jjco/hyz049. [Epub ahead of print]

PMID:
31008509
21.

Vanadium disulfide flakes with nanolayered titanium disulfide coating as cathode materials in lithium-ion batteries.

Li L, Li Z, Yoshimura A, Sun C, Wang T, Chen Y, Chen Z, Littlejohn A, Xiang Y, Hundekar P, Bartolucci SF, Shi J, Shi SF, Meunier V, Wang GC, Koratkar N.

Nat Commun. 2019 Apr 16;10(1):1764. doi: 10.1038/s41467-019-09400-w.

22.

Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.

Nishioka N, Uchino J, Hirai S, Katayama Y, Yoshimura A, Okura N, Tanimura K, Harita S, Imabayashi T, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K.

J Clin Med. 2019 Apr 3;8(4). pii: E450. doi: 10.3390/jcm8040450.

23.

The effect of telmisartan on the ventricular systolic function in dogs with experimental supraventricular tachyarrhythmia.

Kawaguchi T, Hashimoto R, Yasukawa Y, Yamada S, Yoshimura A, Hirao D, Ohmori T, Fukushima R.

J Vet Med Sci. 2019 May 31;81(5):717-722. doi: 10.1292/jvms.18-0772. Epub 2019 Apr 8.

24.

[Curative Resection of Locally Advanced Rectal Cancer with Synchronous Liver Metastasis after Long-Term Chemotherapy].

Ueda T, Sadamitsu T, Yokoyama T, Tanaka T, Kirihataya Y, Yoshimura A.

Gan To Kagaku Ryoho. 2019 Mar;46(3):496-498. Japanese.

PMID:
30914593
25.

Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions.

Imabayashi T, Uchino J, Yoshimura A, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K.

Cancers (Basel). 2019 Mar 22;11(3). pii: E410. doi: 10.3390/cancers11030410.

26.

T cell and periosteum cooperation in osteoclastogenesis induced by lipopolysaccharide injection in transplanted mouse tibia.

Kobayashi H, Ukai T, Shiraishi C, Ozaki Y, Yoshimura A, Hara Y.

J Dent Sci. 2018 Sep;13(3):226-233. doi: 10.1016/j.jds.2018.03.001. Epub 2018 Mar 31.

27.

Tissue regulatory T cells and neural repair.

Ito M, Komai K, Nakamura T, Srirat T, Yoshimura A.

Int Immunol. 2019 May 21;31(6):361-369. doi: 10.1093/intimm/dxz031.

PMID:
30893423
28.

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.

Yoshimura A, Yamada T, Okura N, Takeda T, Hirose K, Kubota Y, Shiotsu S, Hiranuma O, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Cancers (Basel). 2019 Mar 15;11(3). pii: E365. doi: 10.3390/cancers11030365.

29.

MYO1C stabilizes actin and facilitates the arrival of transport carriers at the Golgi complex.

Capmany A, Yoshimura A, Kerdous R, Caorsi V, Lescure A, Del Nery E, Coudrier E, Goud B, Schauer K.

J Cell Sci. 2019 Apr 26;132(8). pii: jcs225029. doi: 10.1242/jcs.225029.

PMID:
30872458
30.

Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK rats.

Nagao S, Kugita M, Kumamoto K, Yoshimura A, Nishii K, Yamaguchi T.

PLoS One. 2019 Mar 14;14(3):e0207461. doi: 10.1371/journal.pone.0207461. eCollection 2019.

31.

Sulfonylimino Group Transfer Reaction Using Imino-λ³-iodanes with I₂ as Catalyst Under Metal-free Conditions.

Yoshimura A, Makitalo CL, Jarvi ME, Shea MT, Postnikov PS, Rohde GT, Zhdankin VV, Saito A, Yusubov MS.

Molecules. 2019 Mar 11;24(5). pii: E979. doi: 10.3390/molecules24050979.

32.

miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity.

Łyszkiewicz M, Winter SJ, Witzlau K, Föhse L, Brownlie R, Puchałka J, Verheyden NA, Kunze-Schumacher H, Imelmann E, Blume J, Raha S, Sekiya T, Yoshimura A, Frueh JT, Ullrich E, Huehn J, Weiss S, Gutierrez MG, Prinz I, Zamoyska R, Ziętara N, Krueger A.

PLoS Biol. 2019 Mar 11;17(3):e2006716. doi: 10.1371/journal.pbio.2006716. eCollection 2019 Mar.

33.

NR4A transcription factors limit CAR T cell function in solid tumours.

Chen J, López-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, Yoshimura A, Scott-Browne JP, Rao A.

Nature. 2019 Mar;567(7749):530-534. doi: 10.1038/s41586-019-0985-x. Epub 2019 Feb 27.

PMID:
30814732
34.

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer.

Yamada T, Hirai S, Katayama Y, Yoshimura A, Shiotsu S, Watanabe S, Kikuchi T, Hirose K, Kubota Y, Chihara Y, Harada T, Tanimura K, Takeda T, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Cancer Med. 2019 Apr;8(4):1521-1529. doi: 10.1002/cam4.2037. Epub 2019 Feb 21.

35.

Amyloid tumor of the breast.

Mori M, Kotani H, Sawaki M, Hattori M, Yoshimura A, Gondo N, Adachi Y, Kataoka A, Sugino K, Horisawa N, Terada M, Ozaki Y, Iwata H.

Surg Case Rep. 2019 Feb 19;5(1):31. doi: 10.1186/s40792-019-0591-z.

36.

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression.

Nakamura K, Sawada K, Miyamoto M, Kinose Y, Yoshimura A, Ishida K, Kobayashi M, Shimizu A, Nakatsuka E, Hashimoto K, Mabuchi S, Kimura T.

Oncotarget. 2019 Jan 18;10(6):673-683. doi: 10.18632/oncotarget.26586. eCollection 2019 Jan 18.

37.

C/EBPβ and YY1 bind and interact with Smad3 to modulate lipopolysaccharide-induced amelotin gene transcription in mouse gingival epithelial cells.

Nakayama Y, Kobayashi R, Iwai Y, Noda K, Yamazaki M, Kurita-Ochiai T, Yoshimura A, Ganss B, Ogata Y.

FEBS Open Bio. 2018 Dec 27;9(2):276-290. doi: 10.1002/2211-5463.12566. eCollection 2019 Feb.

38.

The overall survival of breast cancer patients without adjuvant therapy.

Onishi S, Sawaki M, Ishiguro J, Kataoka A, Iwase M, Sugino K, Adachi Y, Gondo N, Kotani H, Yoshimura A, Hattori M, Matsuo K, Yatabe Y, Iwata H.

Surg Today. 2019 Jul;49(7):610-620. doi: 10.1007/s00595-019-01775-z. Epub 2019 Feb 7.

PMID:
30730005
39.

Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.

Nakatsukasa H, Oda M, Yin J, Chikuma S, Ito M, Koga-Iizuka M, Someya K, Kitagawa Y, Ohkura N, Sakaguchi S, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Yamanaka S, Takamura-Enya T, Lu Q, Yoshimura A.

Int Immunol. 2019 Apr 26;31(5):335-347. doi: 10.1093/intimm/dxz008.

PMID:
30726915
40.

Prediction of pathological margin status using preoperative contrast-enhanced MRI in patients with early breast cancer who underwent skin-sparing mastectomy.

Kataoka A, Sawaki M, Okumura S, Onishi S, Iwase M, Sugino K, Ishiguro J, Gondo N, Kotani H, Yoshimura A, Hattori M, Sasaki E, Yatabe Y, Yoshimura K, Omi K, Iwata H.

Breast J. 2019 Mar;25(2):202-206. doi: 10.1111/tbj.13194. Epub 2019 Jan 30.

PMID:
30697867
41.

The Persistent Generalized Muscle Contraction in Siblings with Molybdenum Cofactor Deficiency Type A.

Yoshimura A, Kibe T, Hasegawa H, Ichida K, Koshimizu E, Miyatake S, Matsumoto N, Yokochi K.

Neuropediatrics. 2019 Apr;50(2):126-129. doi: 10.1055/s-0039-1677869. Epub 2019 Jan 29.

PMID:
30695801
42.

[Curative Resection of Locally Advanced Rectal Cancer with Para-Aortic Lymph Node Swelling after Long-Term Chemotherapy].

Sadamitsu T, Ueda T, Tanaka T, Yokoyama T, Kirihataya Y, Yoshimura A.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2051-2053. Japanese.

PMID:
30692281
43.

Isotope-Engineering the Thermal Conductivity of Two-Dimensional MoS2.

Li X, Zhang J, Puretzky AA, Yoshimura A, Sang X, Cui Q, Li Y, Liang L, Ghosh AW, Zhao H, Unocic RR, Meunier V, Rouleau CM, Sumpter BG, Geohegan DB, Xiao K.

ACS Nano. 2019 Feb 26;13(2):2481-2489. doi: 10.1021/acsnano.8b09448. Epub 2019 Jan 28.

PMID:
30673215
44.

Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.

Yoshimura A, Yamada T, Tsuji T, Hamashima R, Shiotsu S, Yuba T, Takumi C, Uchino J, Hiraoka N, Takayama K.

Thorac Cancer. 2019 Mar;10(3):557-563. doi: 10.1111/1759-7714.12979. Epub 2019 Jan 23.

45.

Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer.

Katayama Y, Yamada T, Tanimura K, Yoshimura A, Takeda T, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Thorac Cancer. 2019 Mar;10(3):526-532. doi: 10.1111/1759-7714.12969. Epub 2019 Jan 21.

46.

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.

Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M, Yoshimura A, Shiotsu S, Matsumoto I, Watanabe S, Kikuchi T, Miura S, Tanaka H, Kitazaki T, Yamaguchi H, Mukae H, Uchino J, Uehara H, Takayama K, Yano S.

Nat Commun. 2019 Jan 16;10(1):259. doi: 10.1038/s41467-018-08074-0.

47.

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.

Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T.

Nat Microbiol. 2019 Mar;4(3):492-503. doi: 10.1038/s41564-018-0333-1. Epub 2019 Jan 14.

PMID:
30643240
48.

Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis.

Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Takeshita M, Kassai Y, Miyazaki T, Morita R, Niki Y, Kaneko Y, Yasuoka H, Yamaoka K, Yoshimura A, Takeuchi T.

Arthritis Res Ther. 2019 Jan 10;21(1):14. doi: 10.1186/s13075-018-1802-x.

49.

Recurrence of Left Ventricular Outflow Tract Obstruction Requiring Alcohol Septal Ablation after Transcatheter Aortic Valve Implantation.

Kitahara H, Mastuura K, Sugiura A, Yoshimura A, Muramatsu T, Tamura Y, Nakayama T, Fujimoto Y, Matsumiya G, Kobayashi Y.

Case Rep Cardiol. 2018 Dec 2;2018:5026190. doi: 10.1155/2018/5026190. eCollection 2018.

50.

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.

Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, Yoshida Y, Takayama T, Imai H, Nozawa K, Sangai T, Yoshimura A, Hasegawa Y, Yamaguchi T, Shimozuma K, Ohashi Y.

PLoS One. 2019 Jan 9;14(1):e0208118. doi: 10.1371/journal.pone.0208118. eCollection 2019.

Supplemental Content

Loading ...
Support Center